Your browser doesn't support javascript.
loading
Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514).
Soussain, Carole; Malaise, Denis; Choquet, Sylvain; Ghesquières, Hervé; Houillier, Caroline.
Afiliação
  • Soussain C; Hematology, Institut Curie, Site Saint-Cloud, Saint-Cloud, France. Electronic address: carole.soussain@curie.fr.
  • Malaise D; Ophthalmology, Institut Curie, Site Paris, Université Paris V Descartes et PSL (Paris Science et Lettre), Paris, France.
  • Choquet S; Hematology, APHP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Ghesquières H; Hematology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite, France.
  • Houillier C; APHP, Sorbonne Université, IHU, ICM, Neurology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Eur J Cancer ; 189: 112909, 2023 08.
Article em En | MEDLINE | ID: mdl-37301714
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Neoplasias da Retina / Linfoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Neoplasias da Retina / Linfoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article